Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel

N Engl J Med. 2022 Jan 27;386(4):399-401. doi: 10.1056/NEJMc2117385. Epub 2021 Dec 22.

Authors

Khitam Muhsen¹, Nimrod Maimon², Ami Mizrahi³, Baruch Varticovschi³, Omri Bodenheimer³, Udi Gelbshtein⁴, Itamar Grotto⁵, Dani Cohen⁶, Ron Dagan⁵

Affiliations

¹ Tel Aviv University, Tel Aviv, Israel [email protected].
² Soroka University Medical Center, Beer-Sheva, Israel.
³ Israeli Ministry of Health, Airport City, Israel.
⁴ Israeli Ministry of Health, Jerusalem, Israel.
⁵ Ben-Gurion University of the Negev, Beer-Sheva, Israel.
⁶ Tel Aviv University, Tel Aviv, Israel.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
BNT162 Vaccine / administration & dosage*
COVID-19 / epidemiology*
COVID-19 / prevention & control
COVID-19 Vaccines*
Female
Hospitalization / statistics & numerical data
Humans
Immunization, Secondary*
Incidence
Israel / epidemiology
Long-Term Care*
Male
Middle Aged
Nursing Homes
Vaccine Efficacy / statistics & numerical data*

Substances

COVID-19 Vaccines
BNT162 Vaccine

Supplementary concepts

COVID-19 vaccine booster shot